A new study evaluating the impact of aging on health care costs from birth until very old age determines that the average 55-year-old retiree will spend $226,000 more on health care than a person retiring at age 65, assuming they both live to age 85.
Dr. Reddy's Laboratories Ltd. said Tuesday its net income climbed 67 percent in the fiscal fourth quarter. The company said it earned 5.7 billion rupees ($104 million), or 60 cents per U.S. share. Its revenue grew 26 percent to 33.4 billion rupees ($611 million)
Those who take products containing zolpidem, best know by the drug’s brand name Ambien, are now being advised by the Food and Drug Administration to take less of the medication. Patients who take the drug, especially the extended release version, are advised not to drive the next day as levels of the drug remain high in the body
A surprising new report questions public health efforts to get Americans to sharply cut back on salt, saying it's not clear whether eating super-low levels is worth the struggle. Make no mistake: Most Americans eat way too much salt, not just from salt shakers but because of sodium hidden inside processed foods and restaurant meals.
The Indian government announced Tuesday the development of a new low-cost vaccine proven effective against a diarrhea-causing virus that is one of the leading causes of childhood deaths across the developing world.The Indian manufacturer of the new rotavirus vaccine pledged to sell it for $1 a dose, a significant discount from the cost of the current vaccines on the market.
Merck Serono, a division of Merck, Darmstadt, Germany, and Quintiles, a provider of biopharmaceutical development and commercial outsourcing services, today announced a new, five-year clinical development agreement. This strategic collaboration is the first-of-its-kind between a biopharmaceutical company and a biopharmaceutical services provider.
Moody's Investors Service on Tuesday lowered the long-term debt ratings of drug maker Merck & Co. The rating agency put Merck on review for downgrade at the beginning of May following the company's plans to buy back about $7.5 billion worth of its shares over the next 12 months. Those...
Drug and medical device maker Hospira Inc. said Tuesday that Dr. Sumant Ramachandra was coming back as senior vice president and chief scientific officer, just two months after he had left the company. Ramachandra, 44, had left Hospira in March to be president of research and development at...
VeriSym SE is a new high-performance optical inspection system designed to verify softgels continuously, in-line after a single encapsulator or off-line in a batch mode. It inspects up to 200,000 softgels per hour within its compact footprint.
AbbVie and Alvine Pharmaceuticals, a leader in celiac disease therapeutics development, announced today that they have entered into a global collaboration to develop a novel oral treatment for patients with celiac disease, currently in Phase 2 development.
Health officials are getting worried that two new viruses could spread around the world. One is a new strain of Bird Flu in China and the other has spread through the Middle East to France and Britain. The viruses are blamed for at least 50 deaths.
France's antitrust authority on Tuesday fined Sanofi 40.6 million euros ($52.6 million) for a "smear campaign" designed to limit sales of generic versions of Plavix. The ruling on the drug, which last year generated global sales of nearly 2.1 billion euros ($2.7 billion), follows a complaint by Teva.
Astellas announced Tuesday a restructuring of its R&D operations including the closure of its OSI Pharmaceuticals and Perseid Therapeutics units in the US. The company, which said the move is designed to "further enhance the ability to generate innovative drugs," also noted that activities at its Astellas Research Institute of America will be scaled back to focus on CNS therapies.
Seattle Genetics, Inc. announced that the FDA has accepted for filing a supplement to the Biologics License Application supporting the use of ADCETRIS for retreatment and extended duration beyond 16 cycles of therapy in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma.
Hospitals nationwide could lose half a billion dollars in federal funding for uninsured patients next year under the national health overhaul — a loss that will hit especially hard in states that decided against expanding Medicaid coverage. Cuts could jump to $4 billion in 2020, according to estimates released Monday by federal health officials.